PLANT

Canntab awarded Health Canada cannabis research licence

Plans to produce oral delivery formulations including extended release, instant release and bi-layered hard pills.


TORONTO — Health Canada has granted Canntab Therapeutics Ltd. a cannabis research licence for continuing research and development at its Markham, Ont. facility.

The manufacturer of cannabinoid and terpene blends in hard pill form for therapeutic application will produce oral delivery formulations.

They’ll include extended release, instant release and bi-layered hard pills after it receives processing and seller licences from Health Canada.

 

Have your say:

Your email address will not be published. Required fields are marked *

*